Search results
Showing 1636 to 1650 of 2105 results for technology appraisal
Lung cancer (non-small cell, advanced, inoperable) - liposomal cisplatin (with chemotherapy) [ID657]
Discontinued Reference number: GID-TAG496
This guideline covers care before, during and after a planned knee, hip or shoulder replacement. It includes recommendations to ensure that people are given full information about their options for surgery, including anaesthesia. It offers advice for healthcare professionals on surgical procedures and ensuring safety during operations. It also offers guidance on providing support and rehabilitation before and after surgery.
Discontinued Reference number: GID-TAG493
In development Reference number: GID-TA10745 Expected publication date: 17 July 2024
In development Reference number: GID-TA11441 Expected publication date: TBC
Evidence-based recommendations on olaparib (Lynparza) for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast cancer after chemotherapy in adults.
Discontinued Reference number: GID-TAG404
Pembrolizumab with chemoradiotherapy for untreated unresectable oesophageal cancer [ID6270]
In development Reference number: GID-TA11303 Expected publication date: TBC
In development Reference number: GID-TA11500 Expected publication date: TBC
Tanezumab for treating pain caused by bone metastases [ID3784]
Discontinued Reference number: GID-TA10922
In development Reference number: GID-TA11511 Expected publication date: TBC
Baricitinib for treating severe or very severe alopecia areata in people 6 to 17 years [ID6541]
In development Reference number: GID-TA11692 Expected publication date: TBC
In development Reference number: GID-TA11760 Expected publication date: TBC
Bevacizumab for the treatment of recurrent glioblastoma multiforme [ID80]
Discontinued Reference number: GID-TAG413
Discontinued Reference number: GID-TAG394